CTOs on the Move

Truly Instrument Limited

www.fastclean.com

 
Truly Instrument Limited is a Alhambra, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.fastclean.com
  • Bldg NDCBU #0301 2620 Concord Ave Ste 106
    Alhambra, CA USA 91803
  • Phone: 626.284.6026

Executives

Name Title Contact Details

Similar Companies

Omni-Tract Surgical

Omni-Tract Surgical is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nova Health Systems Inc

Nova Health Systems Inc is a Utica, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TTI MEDICAL

TTI MEDICAL is a San Ramon, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Certol International

Certol International is a Commerce City, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Transgenomic

Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.  Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.